Published in AIDS Weekly, June 3rd, 1996
The trial, directed by Dr. Stephen R. Raffanti of Vanderbilt University Hospital, Nashville, Tennessee, was a double blind, three month, randomized placebo-controlled study involving adult patients with late stage AIDS (mean CD4 count equals 30).
Data filed with the U.S. Food and Drug Administration (FDA) indicated a significant statistical difference between the groups in four...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.